chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt noted dizziness, heart racing, warmth, and feeling of unease. She "could not catch her breath". Patient went into supine position, drank orange juice, and took deep breathes and felt better. Vitals were 142/80, HR 125, spO2 100%, and temperate 97.1F.
Could not drink water; Could not close lips; Numbness of the face; Tingling sensation; Felt strange; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness of the face), PARAESTHESIA (Tingling sensation), FEELING ABNORMAL (Felt strange), DYSPHAGIA (Could not drink water) and DYSKINESIA (Could not close lips) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness of the face), PARAESTHESIA (Tingling sensation) and FEELING ABNORMAL (Felt strange). On 04-Mar-2021, the patient experienced DYSPHAGIA (Could not drink water) and DYSKINESIA (Could not close lips). On 26-Feb-2021, HYPOAESTHESIA (Numbness of the face), PARAESTHESIA (Tingling sensation) and FEELING ABNORMAL (Felt strange) had resolved. At the time of the report, DYSPHAGIA (Could not drink water) and DYSKINESIA (Could not close lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided by reporter. Treatment medications were not provided
Case number PHEH2014US003614 is an initial spontaneous report received from a pharmacist on 21 FEB 2014 and a follow up report from the pharmacist received on 18 MAR 2014. This report refers to a 16-year-old male patient. His medical history and concomitant medications were not reported. On 06 DEC 2014, he was vaccinated with FLUCELVAX (batch number: 010021A, expiry date: JUN 2014) intramuscularly in the left deltoid at a dose of 0.5 ml. No adverse event was reported following this administration error (inappropriate age at vaccine administration).  Follow up report from the pharmacist received on 18 MAR 2014: The vaccination site was updated.  Following an internal review on 18 AUG 2014 of the data received on 18 MAR 2014, it was identified that the BPI labeling of the event "inappropriate age at vaccine administration" was erroneously captured as listed and hence the labeling was now changed as unlisted and second indication off-label use was added to the case.
Mild itch on face, eyes and arms. Previously reported reaction  was a little more intense and it included my scalp.; Mild itch on face, eyes and arms. Previously reported reaction  was a little more intense and it included my scalp.; This is a spontaneous report from a contactable consumer (Patient). A 67-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 10Feb2021 01:45 (Batch/Lot Number: EL8982) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included high cholesterol, arthritis, glaucoma candidate, GERD, Osteopenia, lumbar radiculopathy penicillin allergy and sulfonamide allergy. Concomitant medication(s) included lovastatin (LOVASTATIN) taken for an unspecified indication, start and stop date were not reported; lansoprazole (LANSOPRAZOLE) taken for an unspecified indication, start and stop date were not reported and unspecified medications. The patient previously took Cortisone, Dexamethasone, Clindamycin, Neurontin, Gabapentin, Carbamazepine, Endocet, Metoprolol, Pamalor and experienced allergies for all medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162B2), via an unspecified route of administration, administered in Arm right on 20Jan2021 02:00 PM (Batch/Lot Number: EL3246) as 1ST DOSE, SINGLE for covid-19 immunisation and expereinced mild itch on face, eyes and arms and scalp. On 10Feb2021 14:15 the patient experienced Mild itch on face, eyes and arms. Previously reported reaction was a little more intense and it included her scalp. No treatment were received for the events. The outcome of the events were recovered on an unspecified date.
wants to know if he can take Zyrtec for his allergies; This is a spontaneous report from a Pfizer-sponsored program via Contactable male consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 04Jul2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient wanted to know if he can take Zyrtec for his allergies on an unspecified date. The outcome of the event was unknown.
hives; Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 infection) and URTICARIA (hives) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Ear infection.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced COVID-19 (Covid-19 infection). On 24-Mar-2021, the patient experienced URTICARIA (hives). The patient was treated with CORTICOSTEROIDS (STEROIDS) for Hives, at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19 infection) and URTICARIA (hives) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, SARS-CoV-2 test: positive (Positive) diagnosed with  Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Long term adverse reaction began within one week of last Moderna dose.  I normally am very healthy, still able to quickly climb any of our tallest mountains, able to ride over 100 miles a week on my bike, etc.  I would have no more than 2 respiratory illnesses a year.  Since my second dose, I have had 10 upper and lower, including two severe respiratory illnesses.  My healthy norm has been reversed.  I normally have a cold, am good for 5 to 10 days, and then I catch something again.
HAD STUFF GOING ON; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included ergocalciferol. On an unspecified date, the patient experienced had stuff going on. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of had stuff going on was not reported. This report was non-serious.
4 weeks after vaccine still c/o pain at site with 35 cm area of erythema overlying site. She came to employee health today to report symptoms. No restriction in ADL's.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024L26A) for COVID-19 vaccination.     Concurrent medical conditions included Bell's palsy (Medical history reported as bell palsy.) and Diabetes (Medical history reported as diabetic).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Shivering; feeling cold; This case was reported by a consumer via call center representative and described the occurrence of shivering in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 7th January 2020, the patient received the 2nd dose of Shingrix. On 7th January 2020, less than a day after receiving Shingrix, the patient experienced shivering and feeling cold. On 8th January 2020, the outcome of the shivering and feeling cold were recovered/resolved.   It was unknown if the reporter considered the shivering and feeling cold to be related to Shingrix.  Additional details were provided as follows: On 23rd October 2019, the patient received 1st dose of Shingrix and had no side effects. In the afternoon the patient received 2nd dose, and in the evening started feeling cold and shivering. The reporter did not consent to follow up.
12/10/98 coughing, wheezing, diaphoresis, weakness. 3 days later seen in ER, c/o substernal chest pain w/radiation to lt arm, shortness of breath.dx:atrial fibrillation w/ rapid ventricular rate admitted to hosp; elective cardioversion
This case was reported by a consumer via interactive digital media and described the occurrence of fever in a 51-year-old female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced fever, general body pain and rash. On an unknown date, the outcome of the fever, general body pain and rash were unknown. It was unknown if the reporter considered the fever, general body pain and rash to be related to SHINGRIX. Additional details were reported as follows: The case was reported on a social media account by a person that the reporter knows and she reported it to all her social media followers. Two days after vaccination the patient had Rash on both arms at inner elbow. The events did not cause the patient to be admitted to the hospital overnight or prolong an existing hospitalization. It was unknown if the reporter consider the events to be life threatening or to result in persistent or significant disability or incapacity. The patient did not die. The events did not require surgical or medical. The events did not result in a congenital anomaly or birth defect. The reporter did not speak with the patient directly nor corresponded in any way with the patient. The reporter had no other detail.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 05-MAY-2016, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 12-MAY-2016, a week after being vaccinated with ZOSTAVAX, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. On or about 19-MAY-2016, the patient sought subsequent treatment at a clinic for ongoing and worsening episodes of shingles outbreaks. The patient has been prescribed LYRICA, TYLENOL, carbamazepine, gabapentin and lidocaine for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX, vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
On Day 3 after the shot, I experienced a sensation in the back of my left leg that felt like a shingles-active area (no rash). Next several days, I have been experiencing hot, heavy, and prickly skin. Not hot externally, just the sensation ? like a constant strong hot flash. No fever. No fatigue. No headache.
Information has been received from a nurse practitioner referring to 1 year old male patient with dermatitis atopic and no known drug allergy. The patient had no illness at time of vaccination. The patient's birth weight was 6lb 4oz. Concomitant therapies included (Oka/Merck) VARIVAX and hepatitis A virus (unspecified). On 10-MAY-2016 at 09:34, the patient was vaccinated with (wistar ra 27-3) M-M-R II lot # L042818  dose 1, subcutaneously in the left thigh. The vaccine was properly stored at 53.2 F for 9 hours and 25 minutes. There were no previous temperature excursions. Digital data logger was involved. No adverse effect was reported. This is one of several reports received rom the same reporter. Additional information has been requested.
beginning approximately 28 hours after vaccination, patient developed dry, hacking cough, tightness in chest, shortness of breath/dyspnea and wheezing with exertion.  Coughing, and chest tightness/wheezing exacerbated by laughing, deep breaths and exertion. Symptoms limited patient from exercising and continued until 6 days after symptoms started.  Day 8 after vaccination, symptoms resolved.  Patient able to resume routine exercising without cough and feelings of shortness of breath/dyspnea.
Client states to have felt light headed after recieving all 5 injections.  Client passed out within 30 seconds, started posturing then had a Seizure.  Posturing and seizure last about 45 seconds.  Ammonia snapped under nose and client came became alert with 15 seconds. Client was very thirsty and had a headache following event. Ambulance was called to have client evaluated.  Mother was also called.  Client evaluated 6/13 and client states to have had no further symptoms.
Right arm became swollen, slightly itchy and red on 7/23 according to mother. Seen in office today. Right arm from below shoulder to 1-2" above elbow red, swollen, warm with clear area elbow to shoulder anterior area upper arm.
no adverse effects reported; possibly inadvertent low dose of MMR II; user error in administering the vaccine, which caused some of the dose to "leak out of the syring and not be given to the patient"; Information has been received from a pharmacist referring to a female patient of unknown age. The patient's pertinent medical history, previously drug reactions, allergies, concurrent conditions and concomitant medications were not reported.      On 18-JUN-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose, frequency, lot# and expiration date were not reported)subcutaneous for prophylaxis. It was a possibly inadvertent low dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) administered (incorrect dose administered). There was no defect with the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) dose itself, but a user error in administering the vaccine, which caused some of the dose to leak out of the syringe and not be given to the patient (product administration error). It was reported that the patient had no prior documentation or any post-vaccination serologic testing for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II). There were no adverse effects reported.
Woke up next morning was very achy knee joints slight headache and fever of 100.4. Also significant soreness at the injection site beginning approximately one hour after the injection.
sore injection site left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore injection site left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011LT0A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore injection site left arm). At the time of the report, VACCINATION SITE PAIN (sore injection site left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-270792 (Patient Link).
Client has history of COPD and CHF.  Three days after the 1st COVID Vaccine, client had some SOB and he called 911.  When the ambulance arrived they had to do CPR on him and got him to the hospital and at the hospital they got him breathing on his own.  From the ER they transferred him to Facility.  He spent 23 days in the hospital and Rehab.  He was told he could take the vaccine.  He was out of the hospital for one week before his 2nd COVID Vaccine. His friend/neighbor is the historian and she states that since he was out of rehab that he was having a lot of extremity swelling.  He then came to the Health Services on 03/29/2021for his 2nd COVID Vaccine.  On 3/30/2021 at 5:45 pm, client went to Pharmacy to pick up his medications, and after 9 pm was found by friend deceased in his car at Pharmacy.   This information was received from friend/neighbor, no local family available.
Patient received her vaccine at 11:30 AM.  Immediately after receiving the Jansen vaccine, the patient reported feeling lightheaded as she stood up.  She sat in our waiting area for about 10 minutes, and reported that she felt as though her tongue was swelling.  We contacted EMS at this point, and provided a dose of Benadryl to the patient at her request.  We brought the patient into our vaccine room where she began to break out into hives.  She vomited several times.  EMS arrived shortly thereafter and checked to see if the patient was experiencing an allergic reaction.  EMS took the patient to the hospital.  At about 2 PM, the patient called the pharmacy to let us know that she was okay.  She said that it was confirmed as an allergic reaction at the hospital.  She indicated that she had received a steroid injection at the hospital and was feeling much better.  We encouraged the patient to call us at any time if she had any further problems or questions.
Seizure like activity. Upper and lower extremities. Jerking, rolling eye balls night of the shot. Lasted 1 minute and another one half a minute.
Information has been received from a health worker via a company representative concerning a 66 year old patient with unknown gender. The patient was diabetic with renal complications and had high blood pressure. The patient had no drug reactions and allergies. On 31-MAR-2015, the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, strength and lot# were not reported, subcutaneously). Concomitant therapies included HUMULIN, metformin, TRADJENTA, levothyroxine sodium (manufacturer unknown), atorvastatin, LODIPIN and lisinopril (+) hydrochlorothiazide (manufacturer unknown). On approximately 31-MAR-2015 (reported as one week ago), the patient developed symptoms of redness and vesicles on cervical part of neck and back of ear. The reporter stated the patient visited office on 06-APR-2015 as the reaction was worse on 05-APR-2015. The reporter stated that the patient was to be prescribed VALTREX (1 gm, 3 times every 10 days) and gabapentin 300 mg as treatment for the events. There was no lab diagnostics performed. The outcome of the events was reported as not recovered. Additional information has been requested.
Large red raised area near site of injection that was very tender and itchy. Treated symptoms with Benadryl.
Increased HR and dizziness.  Provided patient with water and had him lay down in zero gravity chair.  Symptoms resolved after 10 mins.
Same vaccine (FLUAD) administered twice within two weeks of each other. No adverse events reported yet.
I had car accident, when I parked my car/had a crash in that time; "lost my mind" for 2 or 3 seconds/I losses my mind for 2-3 sec, when I parked my car; This spontaneous case was reported by a consumer and describes the occurrence of ROAD TRAFFIC ACCIDENT (I had car accident, when I parked my car/had a crash in that time) and DISTURBANCE IN ATTENTION ("lost my mind" for 2 or 3 seconds/I losses my mind for 2-3 sec, when I parked my car) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Nov-2021 at 8:30 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Nov-2021, the patient experienced ROAD TRAFFIC ACCIDENT (I had car accident, when I parked my car/had a crash in that time) and DISTURBANCE IN ATTENTION ("lost my mind" for 2 or 3 seconds/I losses my mind for 2-3 sec, when I parked my car). On 27-Nov-2021, DISTURBANCE IN ATTENTION ("lost my mind" for 2 or 3 seconds/I losses my mind for 2-3 sec, when I parked my car) had resolved. At the time of the report, ROAD TRAFFIC ACCIDENT (I had car accident, when I parked my car/had a crash in that time) outcome was unknown.            The patient did not take drugs and was in very good health conditions.  The events occurred 24 hours after the vaccine at 13:00, when the patient was in the car. and "lost my mind" for 2 or 3 seconds and had a crash in that time. The patient had not seen a doctor yet.  When the patient was asked for a batch number by the handler, the patient provided the following: 242102517554866024103B7C8E2O42011ECB7C40050569ED4A8; stating that it was the only "identification number" they could see on the vaccination certificate.  The patient did not receive any treatments.